Thursday, August 25th 2016
Vaxinano has signed a research contract with a key player among the world’s top 10 pharmaceutical companies
Hot on the heels of its creation, Vaxinano has signed a research and development contract with a world leader in the pharmaceutical industry. This first contract concerns the development and evaluation of several veterinary vaccines. Professor Betbeder, co-founder of Vaxinano, adds: “We are delighted in the interest shown in Vaxinano's patented technology and the confidence our first industrial partner has shown in us”. This first contract will allow Vaxinano to continue its R & D planning while developing new proofs of concept.